TARO-CLOTRIMAZOLE/BETAMETHASONE DIPROPIONATE

Approval Id: d62798fabd5ccb3a
Drug Approval Canada Name: TARO-CLOTRIMAZOLE/BETAMETHASONE DIPROPIONATE
Product Name: TARO-CLOTRIMAZOLE/BETAMETHASONE DIPROPIONATE
Status: Marketed
Status Date: 2020-04-06
Original Market Date: 2020-04-06
Din: 02496410
Drug Class: Human
Dosage Form: Cream
Route Of Administration: Topical
Schedule: Prescription
Ahfs: 84:06.00
Atc Original: D01AC20 IMIDAZOLES/TRIAZOLES IN COMBINATION WITH CORTICOSTEROIDS
Atc Name: d 01 ac 20
Aig Number: 0216399001
Company Name: Taro Pharmaceuticals Inc
Company Address: 130 East Drive, Brampton, Ontario, Canada, L6T 1C1
Company Detail Path: /organization/taro-pharmaceuticals-inc

CLOTRIMAZOLE

1 % / W/W

BETAMETHASONE (BETAMETHASONE DIPROPIONATE)

0.05 % / W/W

Authorized

Agency

Health Canada

Country

🇨🇦

Approval Date

Jul 4, 2025

Approval ID

d62798fabd5ccb3a

Type

Standard